These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23504154)

  • 1. Practices can stop displaying lists of 'top 10' medicines.
    Vet Rec; 2013 Mar; 172(11):277. PubMed ID: 23504154
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of online pharmacies on veterinary practices.
    Henderson H
    Vet Rec; 2014 Sep; 175(11):286. PubMed ID: 25234461
    [No Abstract]   [Full Text] [Related]  

  • 3. Moves to eliminate 'anticompetitive' practices in the supply of prescription-only veterinary medicines.
    Vet Rec; 2003 Apr; 152(16):482-4. PubMed ID: 12733556
    [No Abstract]   [Full Text] [Related]  

  • 4. VMD drops plans for POM-EA category.
    Vet Rec; 2011 Jun; 168(24):627. PubMed ID: 21685416
    [No Abstract]   [Full Text] [Related]  

  • 5. Facing competition on veterinary medicines supply.
    Vet Rec; 2004 Apr; 154(14):417-8. PubMed ID: 15119890
    [No Abstract]   [Full Text] [Related]  

  • 6. Veterinary strategy for the new farm health planning initiative.
    Vet Rec; 2005 Dec 24-31; 157(26):826-8. PubMed ID: 16377785
    [No Abstract]   [Full Text] [Related]  

  • 7. Independent review group calls for greater transparency in the dispensing of medicines.
    Vet Rec; 2001 May; 148(20):611-4. PubMed ID: 11394794
    [No Abstract]   [Full Text] [Related]  

  • 8. Responding to the Competition Commission's report.
    Scott-Park F
    J Small Anim Pract; 2003 Jun; 44(6):289-90. PubMed ID: 12831108
    [No Abstract]   [Full Text] [Related]  

  • 9. Competition Commission points to complex monopolies in the supply of POMs.
    Vet Rec; 2002 Sep; 151(12):338-9. PubMed ID: 12371688
    [No Abstract]   [Full Text] [Related]  

  • 10. DTI consults on legislation to improve competition in the POMs market.
    Vet Rec; 2005 Feb; 156(9):262-3. PubMed ID: 15765892
    [No Abstract]   [Full Text] [Related]  

  • 11. Veterinary pharmaceuticals--an endangered species?
    Vet Rec; 2001 Oct; 149(17):508. PubMed ID: 11708634
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidance on the Competition Commission's recommendations.
    Vet Rec; 2005 Nov; 157(20):607. PubMed ID: 16284323
    [No Abstract]   [Full Text] [Related]  

  • 13. Competition Commission recommendations: plans for implementation.
    Vet Rec; 2005 Sep; 157(11):302-3. PubMed ID: 16155233
    [No Abstract]   [Full Text] [Related]  

  • 14. Any questions?
    Vet Rec; 2003 May; 152(22):672-4. PubMed ID: 12803392
    [No Abstract]   [Full Text] [Related]  

  • 15. Privilege to dispense.
    Flower PJ
    Vet Rec; 2001 Feb; 148(7):219. PubMed ID: 11266006
    [No Abstract]   [Full Text] [Related]  

  • 16. The CVMA and the veterinary profession in Canada.
    Gauvin J
    Can Vet J; 2015 Jul; 56(7):647-9. PubMed ID: 26130826
    [No Abstract]   [Full Text] [Related]  

  • 17. Veterinary medicines: product update.
    Vet Rec; 2013 Jan; 172(1):10-1. PubMed ID: 23293146
    [No Abstract]   [Full Text] [Related]  

  • 18. Competition in the supply of medicines.
    Lister SA
    Vet Rec; 2004 Apr; 154(16):511; discussion 511-2. PubMed ID: 15130061
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicines update.
    Vet Rec; 2019 May; 184(19):579. PubMed ID: 31072997
    [No Abstract]   [Full Text] [Related]  

  • 20. Veterinary medicines update.
    Vet Rec; 2016 Feb; 178(6):132-3. PubMed ID: 26851100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.